Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
5.00
+0.25 (5.26%)
Sep 17, 2025, 3:21 PM EDT
Veradigm Market Cap
Veradigm has a market cap or net worth of $806.69 million as of September 17, 2025. Its market cap has decreased by -51.43% in one year.
Market Cap
806.69M
Enterprise Value
579.54M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.00
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 806.69M, an increase of 158.70%. That is a compound annual growth rate of 5.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 806.69M | -51.20% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| CytoDyn | 351.92M |
| American Oncology Network | 345.48M |
| Silence Therapeutics | 223.42M |